FATE R&D Expenses
Fate Therapeutics Inc · R&D Expenses
FATE R&D Expenses
Latest reported$24.39Mperiod ending
FATE Quarterly R&D Expenses ($3.32M → $24.39M)
Quarterly R&D Expenses
High-resolution chart · PNG
FATE r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 24,387,000 | |
| 21,785,000 | |
| 25,425,000 | |
| 25,838,000 | |
| 27,430,000 | |
| 29,136,000 | |
| 33,609,000 | |
| 34,650,000 | |
| 34,604,000 | |
| 32,138,000 | |
| 31,816,000 | |
| 34,275,000 | |
| 40,876,000 | |
| 65,629,000 | |
| 87,191,000 | |
| 79,817,000 | |
| 81,307,000 | |
| 72,139,000 | |
| 69,515,000 | |
| 53,130,000 | |
| 48,023,000 | |
| 44,852,000 | |
| 38,982,000 | |
| 30,694,000 | |
| 26,669,000 | |
| 29,278,000 | |
| 25,209,000 | |
| 23,202,000 | |
| 21,631,000 | |
| 17,728,000 | |
| 14,095,000 | |
| 13,637,000 | |
| 16,816,000 | |
| 11,476,000 | |
| 9,887,000 | |
| 8,578,000 | |
| 7,927,000 | |
| 7,966,000 | |
| 6,230,000 | |
| 6,804,000 | |
| 6,782,000 | |
| 6,636,000 | |
| 5,433,000 | |
| 5,003,000 | |
| 4,857,000 | |
| 4,568,000 | |
| 3,865,000 | |
| 4,080,000 | |
| 3,968,000 | |
| 4,522,000 | |
| 3,031,000 | |
| 3,378,000 | |
| 3,067,000 | |
| 2,531,000 | |
| 3,403,000 | |
| 3,315,000 |